| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 131,981 | 127,498 | 125,914 | 120,970 | | Cost of Revenue |
-
| 80,277 | 77,461 | 75,723 | | | Gross Profit | 131,981 | 47,221 | 48,453 | 45,247 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 113,648 | 32,171 | 33,610 | 30,362 | | Non Recurring |
-
| (137) | (168) | (50) | | Others | 3,879 | 3,717 | 3,690 | 3,787 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,621 | 11,470 | 11,321 | 11,148 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 249 | 69 | 107 | 33 | | Earnings Before Interest And Taxes | 14,703 | 11,539 | 11,428 | 11,181 | | Interest Expense | 7,470 | 7,518 | 7,749 | 7,763 | | Income Before Tax | 7,233 | 4,021 | 3,679 | 3,418 | | Income Tax Expense | 3,657 | 1,197 | 2,026 | 1,965 | | Minority Interest | (705) | (290) | (577) | (215) | | | | Net Income From Continuing Ops | 3,576 | 2,534 | 1,076 | 1,238 | | | Non-recurring Events | | Discontinued Operations | 48 | (338) | (89) | (167) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,919 | 2,196 | 987 | 1,071 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,919 | $2,196 | $987 | $1,071 |
|
0.26% Nasdaq 
Income Statement
